Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results - Concepedia

Concepedia

Publication | Closed Access

Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results

339

Citations

0

References

1993

Year

A. Y. Chang, K. Kim, John H. Glick, Tom Anderson, Daniel D. Karp, David H. Johnson

JNCI Journal of the National Cancer Institute

Abstract

Further study of taxol is warranted. In future studies, taxol should be combined with other agents, and granulocyte colony-stimulating factor should be used to ameliorate myelosuppression.